‘We just need someone who’s not crazy’: How the White House decided on Erica Schwartz for CDC director
We Just Need Someone Who’s Not Crazy: White House Chooses Erica Schwartz for CDC Director
We just need someone who s not - As the U.S. Centers for Disease Control and Prevention (CDC) grappled with a chaotic year of leadership transitions and public health crises, the Trump administration made a strategic decision to appoint Erica Schwartz as its next director. The phrase "We just need someone who’s not crazy" became a recurring theme in internal discussions, highlighting the White House’s priority of selecting a reliable figure over ideological alignment. This choice, finalized in April, marked the third attempt to stabilize the agency after a deadly shooting at its headquarters and frequent shifts in public health strategy.
The Confirmation Process and Political Strategy
Schwartz’s confirmation hearing in late April brought her into the spotlight, where she was grilled by Senate officials about her approach to combating the ongoing health challenges. Her nomination, paired with that of Sean Kaufman for Assistant Secretary of Preparedness and Response, was viewed as a calculated effort to reassert control over the CDC’s messaging. The administration aimed to counter the perception that the agency had become a battleground for conflicting health policies, emphasizing the need for a figure who could unify its operations.
Public Health Challenges and Leadership Decisions
Throughout the year, the CDC faced mounting pressure to address a range of public health issues, from managing an Ebola outbreak in Africa to responding to a surge in parasitic diarrhea cases across multiple states. Schwartz’s background as a former deputy surgeon general and retired Coast Guard officer positioned her as a pragmatic choice, aligning with the administration’s push for stability. Her appointment was seen as a departure from earlier candidates who had strongly endorsed the "Make America Healthy Again" slogan, signaling a shift toward more moderate leadership.
While Schwartz’s qualifications were largely praised, some questioned whether her experience in federal health roles would be enough to navigate the agency’s complex challenges. Critics pointed to the need for a director who could not only manage day-to-day operations but also reframe the CDC’s narrative in the wake of recent controversies. The phrase "We just need someone who’s not crazy" resonated with those who believed the agency had been damaged by inconsistent messaging and political infighting.
Her confirmation process was marked by bipartisan support, with some lawmakers expressing confidence in her ability to lead. However, the White House’s broader goal of distancing the Health and Human Services Department from Robert F. Kennedy Jr.—a vocal advocate for alternative vaccine policies—remained a key objective. Despite these efforts, analysts noted that Schwartz’s appointment did not fully address the lingering influence of Kennedy’s agenda on the agency’s direction.
Dr. Amesh Adalja, a public health expert, emphasized that Schwartz’s success would depend on the political environment she inherited. "Her qualifications are solid, but the key issue is the environment she’s expected to navigate," Adalja stated. "If RFK Jr. remains in charge, any changes will feel superficial." This sentiment underscored the tension between the administration’s desire for stability and the ongoing ideological debates shaping the CDC’s role in public health.
Toby Rogers, a prominent vaccine skeptic, criticized the appointment as a setback for the medical freedom movement. "This is a slap in the face to the base that supported Trump in 2016 and 2024," Rogers tweeted. "The White House isn’t even trying to shift the narrative." His comments reflected the broader concern that Schwartz’s selection might be seen as a compromise, failing to align with the more vocal elements of the administration’s health policy agenda.
Monarez, the previous CDC director, had clashed with Kennedy over vaccine policies and was removed from her post within a month of the administration’s change in direction. Her interim replacement, Jim O’Neill, struggled to establish a clear vision for the agency, further fueling calls for a more decisive leader. As the midterm elections approach, the White House continues to prioritize securing a health department that aligns with its messaging and avoids unflattering headlines. Schwartz’s confirmation represents a step toward that goal, though her ability to drive meaningful change remains under scrutiny.